In a 12-week randomized, double-blind trial, MT104 significantly improved verbal memory and global cognition (K-MoCA, SVLT) in patients with mild cognitive impairment versus placebo. The supplement was safe and well-tolerated, suggesting potential to delay Alzheimer’s progression via the microbiota–gut–brain axis.